Redwood Pharma provides a new update regarding divestment of company assets
Stockholm, June 26, 2024. Redwood Pharma today provides an update on the process for divesting the company's assets. After contacts and discussions with a number of potential buyers in the field of ophthalmology, Redwood Pharma has not received any significant offers with commercially attractive terms. The board of directors is evaluating the situation and will provide more information shortly.Redwood Pharma, a company developing next-generation treatments for dry eye, announced on May 23 that due to financial difficulties, it intends to sell the company's assets in an accelerated auction